Class 2 Recall on Emerade Auto-Injector 150 Bausch & Lomb UK

Recalls and Alerts

Class 2 Recall

Class 2 Recall on Emerade Auto-Injector 150 Bausch & Lomb UK

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3849221	EMERADE 150 AUTO-INJECTOR	BAUSCH & LOMB UK	ALL STOCK

For stock enquiries please contact Bausch & Lomb Customer Services, Tel: 020 8781 2991

For medical information enquiries please contact the Pharmacovigilance and Medical Information Officer, Tel: 0208 781 5523, Email: Pharmacovigilance.UK@bausch.com

Email: Pharma_CS@bausch.com - please note, only in-date pens that are returned by patients, will be refunded, (i.e. expiry date of March 2020 onwards).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.